Johnson & Johnson COVID-19 vaccine booster gets FDA panel recommendation

Only a day after recommending an emergency use authorization for Moderna’s booster vaccine dose, the FDA panel of advisers is back with a similar recommendation for Johnson & Johnson’s Janssen COVID-19 vaccine. The committee unanimously voted in favor of granting J&J an emergency use authorization, though the terms under which the booster would be offered differs from the EUA granted … Continue reading

No Responses to “Johnson & Johnson COVID-19 vaccine booster gets FDA panel recommendation”

Post a Comment